Journey Medical (DERM) Invested Capital (2021 - 2026)
Journey Medical's (DERM) quarterly Invested Capital came in at $2.5 million in Q1 2026, up 33.33% YoY from $1.9 million in Q1 2025, and down 55.56% on a QoQ basis from $5.6 million in Q3 2025.
Journey Medical (DERM) Invested Capital (2021 - 2026) Analysis & Trends
Journey Medical (DERM) has 5 years of Invested Capital data on file, last reported at $2.5 million in Q1 2026.
- Quarterly Invested Capital rose 33.33% year-over-year to $2.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.9 million (up 533.33% YoY) and the FY2022 annual result came in at $2.9 million, up 263.05% from the prior year.
- Invested Capital eased to $2.5 million in Q1 2026, from $5.6 million in the prior quarter.
- In the past five years, Invested Capital ranged from a high of $9.9 million in Q2 2023 to a low of $1.9 million in Q1 2025.
- A 4-year average of $5.2 million and a median of $3.8 million in 2025 frame the typical range for Invested Capital.
- Annual changes were most pronounced in 2022 — Invested Capital soared 263.05% — and 2026, when it jumped 33.33%.
- Tracing DERM's Invested Capital over 4 years: stood at $2.9 million in 2022, then jumped by 237.25% to $9.9 million in 2023, then slumped by 43.42% to $5.6 million in 2025, then slumped by 55.56% to $2.5 million in 2026.
- The last three Invested Capital figures came in at $2.5 million (Q1 2026), $5.6 million (Q3 2025), and $3.8 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 9.90 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 4.50 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 3.74 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 1.74 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 73.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 630.00 Mn |
| 10 | Journey Medical | 205.52 Mn | 179.87 Mn | 12.37 Mn | 5.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.00 Mn |
| Mar 31, 2026 | 2.50 Mn |
| Sep 30, 2025 | 5.63 Mn |
| Jun 30, 2025 | 3.75 Mn |
| Mar 31, 2025 | 1.88 Mn |
| Jun 30, 2023 | 9.94 Mn |
| Mar 31, 2023 | 9.91 Mn |
| Dec 31, 2022 | 2.95 Mn |
| Dec 31, 2021 | 812,000.00 |